BioNeex Interviews

BioNeex Interviews are part of the BioNeex vision. They provide a social media exposure to early stage biotech companies and their R&D pipelines in order to attract the right licensing and co-development partners. During the interview the interviewee, typically a biotech CEO, addresses the company’s message to potential partners, investors and other external stakeholders.

All Interviews

Interview with the CSO of Bright Minds Biosciences, Dr.Jan Torleif Pedersen

Clinical StageWed May 31 2023 08:00:03 GMT+0000 (Coordinated Universal Time)

Interview with the CEO of LIDDS, Anders Månsson

Preclinical StageTue Mar 28 2023 18:50:19 GMT+0000 (Coordinated Universal Time)

Interview with the Founder and President of AptamiR Therapeutics, Dr. Marc Thibonnier

Preclinical StageFri Feb 17 2023 04:43:30 GMT+0000 (Coordinated Universal Time)

Interview with the CEO of Moexa Pharmaceuticals, Anthony Desir

Immuno-OncologyTue Nov 29 2022 16:45:00 GMT+0000 (Coordinated Universal Time)

Interview with the Co-Founder & CEO of Oncolyze, Dr. Steven Evans

Preclinical StageMon Oct 17 2022 15:02:12 GMT+0000 (Coordinated Universal Time)

Interview with President & CEO of PepVax, Mahesh Narayanan

ImmunotherapiesTue Jul 05 2022 16:57:03 GMT+0000 (Coordinated Universal Time)

Interview with Co-Founder & CEO of Odylia Therapeutics, Scott Dorfman

Gene TherapyWed Mar 30 2022 18:36:33 GMT+0000 (Coordinated Universal Time)

Interview with President & CEO of RepliCel Life Sciences, Lee Buckler

Cell TherapiesTue Feb 22 2022 21:44:37 GMT+0000 (Coordinated Universal Time)

Interview with President and Director of BioCorRx, Brady Granier

NeurologyThu Feb 10 2022 19:00:04 GMT+0000 (Coordinated Universal Time)